The landscape of dementia prognosis has developed dramatically with the arrival of refined biomarkers, including amyloid PET scans, tau imaging, and blood-dependent exams that could detect Alzheimer's pathology many years right before indicators emerge. Even though these technological advances stand for impressive development in knowledge neurodege